Colon Cancer News and Research RSS Feed - Colon Cancer News and Research

Every year, about one million new cases of colon cancer are diagnosed worldwide. About 150,000 new cases are detected each year in the United States. Over a lifetime, about 1 in 19 people develop colon cancer and nearly 50,000 people are expected to die from it in the U.S. this year. According to the American Cancer Society, colon cancer is the third leading cause of cancer-related death in the U.S., accounting for about 10 percent of all cancer deaths.
RTFCCR grant supports ASCOLT study that evaluates effectiveness of Aspirin in colorectal cancer patients

RTFCCR grant supports ASCOLT study that evaluates effectiveness of Aspirin in colorectal cancer patients

Rising Tide Foundation for Clinical Cancer Research, an international private foundation based in Switzerland, has awarded a US $800,000 grant to be released over two years for the ASCOLT study conducted by Dr John Chia, Senior Consultant Medical Oncologist at the Division of Medical Oncology, National Cancer Centre Singapore. [More]
Scientists reveal why loss of CD73 enzyme in human cancer promotes tumor progression

Scientists reveal why loss of CD73 enzyme in human cancer promotes tumor progression

Scientists have shown for the first time why loss of the enzyme CD73 in human cancer promotes tumor progression. [More]
NYC’s colorectal cancer screening rates boosted and racial disparities eliminated

NYC’s colorectal cancer screening rates boosted and racial disparities eliminated

A concerted effort to increase colorectal cancer screening rates led to a dramatic increase in NYC screening colonoscopy rates among average-risk men and women and eliminated racial/ethnic disparities in screening [More]
New coalition formed to boost colorectal cancer screening rates in New York City

New coalition formed to boost colorectal cancer screening rates in New York City

A coalition formed by the New York City Department of Health and Mental Hygiene which included a team from Mount Sinai to increase colorectal cancer screening rates in New York City resulted in a 40 percent increase in screening rates over four years. [More]
New approach helps Group Health to increase rates of lifesaving screening for colon cancer

New approach helps Group Health to increase rates of lifesaving screening for colon cancer

Mailing yearly stool kits--an alternative to the often-dreaded colonoscopy--has helped Group Health to boost rates of lifesaving screening for colon cancer, according to new research from Group Health Research Institute. [More]
EU-funded research project aims to reduce oxidation in processed meat products

EU-funded research project aims to reduce oxidation in processed meat products

An EU-funded research project is to make sausages, patties and other meat products healthier in the future. Researchers at Lund University in Sweden, the Swedish University of Agricultural Sciences (SLU) and four other European research institutions have launched a joint project to reduce the risk of colon cancer - the most common cancer of the gastrointestinal tract in Sweden. [More]
Sausages With Antioxidants From Berries To Prevent Cancer

Sausages With Antioxidants From Berries To Prevent Cancer

An EU-funded research project is to make sausages, patties and other meat products healthier in the future. [More]
New findings reveal association between colorectal cancer and melanoma drug treatment

New findings reveal association between colorectal cancer and melanoma drug treatment

Veteran cancer reseacher Prof. Emeritus Alexander Levitzki of Hebrew University of Jerusalem says new findings show link between colorectal cancer and melanoma drug treatment knoqwn as "NT157" in two recently published studies in journal, "Ocogene." [More]
Cancer survivors' journeys chronicled by Bethlehem artist and cancer survivor Susan Schaffer

Cancer survivors' journeys chronicled by Bethlehem artist and cancer survivor Susan Schaffer

Chronicling the journeys of cancer survivors, friends and family has been an emotional process, one filled with joy and shared sorrow for Bethlehem artist and cancer survivor Susan H. Schaffer. As part of her Visions of Hope series of acrylic paintings, Susan offers insight into the windows of the soul - her collection captures the eyes of the people willing to share their respective cancer journeys with her. [More]
NTU Singapore scientists harness dead bacteria to destroy colon tumours cells effectively

NTU Singapore scientists harness dead bacteria to destroy colon tumours cells effectively

Scientists from Nanyang Technological University have successfully used dead bacteria to kill colorectal cancer cells. Harvesting the Clostridium sporogenes bacteria found commonly in soil, the NTU team was able to harness the bacteria in its dead form, and its secretions, to destroy colon tumours cells effectively. [More]
Researchers team up to evaluate biological and genetic differences of GI cancers in race, ethnicity

Researchers team up to evaluate biological and genetic differences of GI cancers in race, ethnicity

Americans of African descent are at a significantly higher risk for developing and dying from Gastrointestinal (GI) cancers, which include colorectal and pancreatic cancers, compared to individuals who are of Caucasian descent. [More]
Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

Scientists at the Salk Institute have uncovered a molecule whose mutation leads to the aggressive growth of a common and deadly type of lung cancer in humans. [More]
University of Kansas professor recognized with MERIT Award

University of Kansas professor recognized with MERIT Award

Emily Scott, professor of medicinal chemistry at the University of Kansas, has been recognized with a MERIT Award from the National Institutes of Health's National Institute of General Medical Sciences. It's a rare and important recognition -- researchers can receive them only once in a career. [More]
Research focuses on understanding racial, ethnic disparities in colon cancer outcomes

Research focuses on understanding racial, ethnic disparities in colon cancer outcomes

Blase Polite, MD, has expertise in the treatment of gastrointestinal malignancies, with a particular focus on colon, rectal, and anal cancers, and neuroendocrine (carcinoid) tumors. [More]
PCF announces 19 new Young Investigator Awards

PCF announces 19 new Young Investigator Awards

The Prostate Cancer Foundation announced 19 new Young Investigator (YI) Awards at the 22nd Annual Scientific Retreat in Washington, DC, held October 8-10, 2015. Awardees were selected from a pool of 107 applicants from 65 institutions in 9 countries. [More]
CNIO researchers identify molecular mechanisms that determine cancer predisposition in DBA patients

CNIO researchers identify molecular mechanisms that determine cancer predisposition in DBA patients

Researchers from the Tumour Suppression Group at the Spanish National Cancer Research Centre, headed by Manuel Serrano, have discovered the molecular mechanisms that determine cancer predisposition in patients with Diamond-Blackfan anaemia (DBA). [More]
New book suggests ways to reduce medical reversals

New book suggests ways to reduce medical reversals

Medical reversal—when accepted medical interventions are abandoned because they are found to be ineffective—is the "most important problem in medicine today," according to the authors of a new book: Ending Medical Reversal. [More]
Researchers study effect of immune tolerance on certain cancer risks

Researchers study effect of immune tolerance on certain cancer risks

For a malignant tumor to form, cancer cells must evade the immune system's attack. Numerous studies have already shown that cancer spreads particularly aggressively if there is an unfavorable balance between suppressing and active immune cells in the tumor microenvironment. "But we didn't know whether this is a consequence of an aggressive tumor or rather its cause," says Rudolf Kaaks, epidemiologist at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). [More]
UT Southwestern announces launch of new health initiative

UT Southwestern announces launch of new health initiative

UT Southwestern Medical Center today announced the launch of "Call Out Cancer," a new health initiative designed to promote awareness, early detection, and prevention of all types of cancer. [More]
Clinical trial shows nivolumab drug improves overall survival, quality of life in lung cancer patients

Clinical trial shows nivolumab drug improves overall survival, quality of life in lung cancer patients

An international team of cancer researchers that included UT Southwestern Medical Center physicians announced "game-changing results" using the immunotherapy drug nivolumab to treat certain lung cancers that failed to respond to first-line therapies. [More]
Advertisement
Advertisement